Clin2
NCT05733910Possibly a fitRecruiting

Carbon ion radiation for adenoid cystic cancer in the head and neck

Carcinoma, Adenoid CysticHead and Neck Cancer

Part of Cancer clinical trials.

This trial tests a type of high-precision radiation (carbon ions) given to shrink head and neck adenoid cystic carcinoma that cannot be fully removed with surgery. It may help control the tumor while limiting damage to nearby normal tissues.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
42 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have confirmed (biopsy-proven) adenoid cystic carcinoma in the head and neck
  • Your tumor can’t be fully removed, or there’s leftover visible disease after surgery, or surgery is possible but you prefer not to have it
  • Your cancer has not spread to distant organs, or it’s limited to 1–3 spots in the lung or bone
  • You have not had any previous radiation to the head and neck area
  • You are 18 or older and well enough to do treatment (Karnofsky score 70 or higher)
  • Your lymph node spread is limited to only the same side neck areas I and II (no more than cN1/pN1)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06472570Recruiting
Targeted radiation for head and neck tumors

This trial tests a precise type of radiation called stereotactic radiosurgery for people with head or neck tumors. It may be an option for those who need radiation or chemoradiation as their main treatment or after surgery.

Gliwice, Gliwicw
NCT06137274Recruiting· Phase 2
Adaptive radiation boost for head and neck cancer

This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.

Tampa, Florida
NCT04974866Recruiting· Phase 2
Targeted pills for advanced adenoid cystic cancer that keeps growing

This Phase 2 trial studies targeted “tyrosine kinase inhibitor” pills for adenoid cystic carcinoma that has spread or cannot be cured with surgery or radiation and is growing despite prior treatment. It’s looking for whether these pills can shrink tumors or slow progression and is mainly for adults with measurable disease on recent scans.

Qingdao, Shandong
NCT07253402Recruiting
Microbiota-guided radiation therapy for head and neck cancer

This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.

Milan, Milan
NCT07507578Recruiting
Biology study for head and neck adenoid cystic carcinoma

This study uses advanced tests on tissue and blood samples to understand why adenoid cystic carcinoma (a type of head and neck cancer) spreads. It aims to find new clues that may help improve future treatments.

Milan
NCT04214366Recruiting· Phase 2
Carbon ion radiation for head and neck adenoid cystic carcinoma

This trial studies carbon ion radiation (a specific type of high-energy radiation) for people with head and neck adenoid cystic carcinoma when surgery isn’t possible or was incomplete. It may help shrink or control the cancer while limiting side effects compared with other approaches.

Heidelberg

Hear when a new Head and Neck Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.